Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C de Mey

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Arzneimittel-Forschung|September 20, 2000
Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxolH Matthys, C de Mey, C Carls, et al.
Clinical Neuropharmacology|August 2, 2001
Influence of the dopamine agonist alpha-dihydroergocryptine on the pharmacokinetics of levodopa in patients with Parkinson's diseaseD Minea, I Varga, C Falup-Pecurariu, et al.
Arzneimittel-Forschung|April 1, 1994
[Pharmacodynamic equivalence and clinical trial of a new fluorocarbon-free glycerol trinitrate pump spray with low ethanol content in comparison to a fluorocarbon-containing reference spray and a fluorocarbon-free pump spray with high ethanol content]K Erb, C de Mey, T Zimmermann, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Clinical pharmacological equivalence of a novel FCH-free GTN spray with low ethanol content vs a FCH-containing GTN sprayC de Mey, K Erb, T Zimmermann, et al.
Clinical Pharmacology and Therapeutics|March 1, 1994
Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humansC de Mey, K Breithaupt, J Schloos, et al.
Arzneimittel-Forschung|May 1, 1991
[Evaluation of pharmacodynamic equivalence of glycerol trinitrate-containing sprays for oral administration with or without chlorofluorocarbons ]K A Erb, C de Mey, G K Wolf, et al.
British Journal of Clinical Pharmacology|January 1, 1983
Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjectsG L Shepherd, P J Lewis, I A Blair, et al.
Journal of Chromatography|September 1, 1989
Routine measurement of plasma catecholamines in clinical pharmacology by high-performance liquid chromatography with electrochemical detectionI Meineke, E Stüwe, E M Henne, et al.
L'Encephale|July 24, 2003
[Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS]S-N Yao, J Cottraux, I Note, et al.
Regional Anesthesia and Pain Medicine|November 15, 2001
A paravenous approach for the saphenous nerve blockJ C De Mey, L J Deruyck, G Cammu, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Arzneimittel-Forschung|September 20, 2000
Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxolH Matthys, C de Mey, C Carls, et al.
Clinical Neuropharmacology|August 2, 2001
Influence of the dopamine agonist alpha-dihydroergocryptine on the pharmacokinetics of levodopa in patients with Parkinson's diseaseD Minea, I Varga, C Falup-Pecurariu, et al.
Arzneimittel-Forschung|April 1, 1994
[Pharmacodynamic equivalence and clinical trial of a new fluorocarbon-free glycerol trinitrate pump spray with low ethanol content in comparison to a fluorocarbon-containing reference spray and a fluorocarbon-free pump spray with high ethanol content]K Erb, C de Mey, T Zimmermann, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Clinical pharmacological equivalence of a novel FCH-free GTN spray with low ethanol content vs a FCH-containing GTN sprayC de Mey, K Erb, T Zimmermann, et al.
Clinical Pharmacology and Therapeutics|March 1, 1994
Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humansC de Mey, K Breithaupt, J Schloos, et al.
Arzneimittel-Forschung|May 1, 1991
[Evaluation of pharmacodynamic equivalence of glycerol trinitrate-containing sprays for oral administration with or without chlorofluorocarbons ]K A Erb, C de Mey, G K Wolf, et al.
British Journal of Clinical Pharmacology|January 1, 1983
Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjectsG L Shepherd, P J Lewis, I A Blair, et al.
Journal of Chromatography|September 1, 1989
Routine measurement of plasma catecholamines in clinical pharmacology by high-performance liquid chromatography with electrochemical detectionI Meineke, E Stüwe, E M Henne, et al.
L'Encephale|July 24, 2003
[Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS]S-N Yao, J Cottraux, I Note, et al.
Regional Anesthesia and Pain Medicine|November 15, 2001
A paravenous approach for the saphenous nerve blockJ C De Mey, L J Deruyck, G Cammu, et al.
Pageof 12